Hualan Biological Bacterin Inc.’s Net Profit Rose 24.8% in First Three Quarters of 2023

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 629.7 million yuan in the first three quarters of 2023, up 24.8% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 7.8 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 22.8%.